Elizabeth’s journey with Duchenne Muscular Dystrophy (DMD) began when her son was diagnosed at the age of five. In this episode, Elizabeth reflects on the diagnosis of her son, her daughter’s and her own carrier diagnosis, family life, her coping mechanisms and management of the disease. Although her and her family’s lives have been impacted by DMD, her future outlook is positive and inspiring. Listen to the podcast for more.

To hear more episodes, subscribe to the Take on Duchenne North America podcast on your favorite podcast platform, such as:

Elizabeth Floyd
Elizabeth Floyd

A military spouse and mother of four young children, Elizabeth’s journey with DMD began when her son was diagnosed at the age of five. Elizabeth shares the importance of support and accessibility for all those touched by DMD, while also raising awareness for the disease and emphasizing the importance of surveillance and treatment for carriers like herself and her daughter.

Podcast Host

Jonathan Blaize, Ph.D.
Jonathan Blaize, Ph.D., BCMAS I PTC Therapeutics

Jonathan Blaize received his PhD in Neuroscience from the City University of New York before joining the faculty at Wagner College where he earned tenure and rank of Associate Professor. A learner by nature, Jon studied the molecular underpinnings of vision and neural inhibition, epigenetic remodeling, and phthalate driven endocrine disruption during his academic tenue. Jon taught more than 20 different classes, developed new courses and designed curricula while also serving as Co-Director of Pre-Professional Programs, Physician’s Assistant Advisor, Grants Coordinator, and curriculum assessment consultant, to name a few. Having focused on translational research throughout his career, and with a desire to engage the rare disease community while leveraging his vast experience in education, Jon pursued board certification in Medical Affairs and transitioned to the role of Medical Science Liaison at PTC Therapeutics in December of 2021. Jon remains passionate about patient care, disease state awareness, education access and research advancement and is thrilled to provide a platform for patients, care providers and scientists to share their experiences and knowledge on the Take-On Duchenne North American Podcast.

US-DMD-0304 I April 2023

PTC Therapeutics has provided financial compensation to Elizabeth Floyd for the time to conduct this interview.

Trademarks, registered or otherwise, are the property of their respective owner(s).